MapLight Therapeutics

About:

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Website: https://maplightrx.com

Twitter/X: Maplightrx

Top Investors: Novo Holdings, 5AM Ventures, Michael J. Fox Foundation, Cowen Healthcare Investments

Description:

MapLight Therapeutics offers a platform designed to discover and develop therapeutics for brain disorders. It combines single-cell transcriptomics and optogenetics to identify novel drug targets and develop effective therapies for brain disorders.

Total Funding Amount:

$268M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)maplightrx.com

Founders:

Chris Kroeger, Karl Deisseroth, Karoly Nikolich, Robert Malenka

Number of Employees:

11-50

Last Funding Date:

2023-10-30

IPO Status:

Private

Industries: